Company intelligence / Profile preview

LC Sciences

Ownership: Private
Development stage: Other

Overview

LC Sciences offers advanced genomics/proteomics services including custom microarrays, RNA-seq/transcriptome analysis, peptide arrays for proteomic studies, metagenomics solutions. Their technologies are widely used in academic and industry research to accelerate biomarker discovery and drug development. They do not have a therapeutic pipeline but enable discoveries across biomedical fields.

Therapeutic areas: OncologyCardiovascularNeurologyInfectious Diseases
Modalities: Synthetic oligonucleotidePeptidesProtein (for arrays and proteomic profiling)Nucleic acid (DNA/RNA sequencing and analysis)Small molecule (in context of biomarker discovery/drug development support)
Industry: Drug Discovery Services

Beyond the preview

Go deeper on LC Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LC Sciences.

Explore the full profile